Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Hinge Health Inc is a technology platform for individuals seeking to treat and prevent joint and muscle pain. Through a combination of AI-powered motion tracking technology, the Company's platform helps members address chronic musculoskeletal (MSK) conditions, enables improved member outcomes and supports cost reductions for its clients.
View stock
VS
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
View stock

Stock highlights

Stock comparison highlights
Stock name
Hinge HealthAbbVie
Last price
$114.32$294.89
Currency
USD
USD
$9.2B$521B
85.6350.77
$1.34$5.81
--
0$6.83
02.35%
Sector
HealthHealth
Employees
1,43757,000
Ticker
$HNGE$ABBV
Primary listing
NYSENYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in $HNGE or $ABBV on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.